Viewing Study NCT00312351


Ignite Creation Date: 2025-12-24 @ 11:45 PM
Ignite Modification Date: 2026-02-11 @ 5:19 PM
Study NCT ID: NCT00312351
Status: TERMINATED
Last Update Posted: 2007-01-15
First Post: 2006-04-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD)
Sponsor: Eyetech Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AMD View
None Age-Related Macular Degeneration View
None Macular Degeneration View
None Macugen View
None pegaptanib sodium View
None ERG View
None specular microscopy View
None Age-Related Mcular Degeneration (AMD) View